ABIN2840363
antibody from antibodies-online
Targeting: HHAT
FLJ10724, GUP2, MART-2, MART2, rasp, sit, ski, Skn
Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2840363 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Hedgehog Acyltransferase (HHAT) (AA 30-59), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 30-59, N-Term
- Antibody clone number
- RB27002
- Vial size
- 80 μL
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Submitted references Skinny hedgehog, an acyltransferase required for palmitoylation and activity of the hedgehog signal.
Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes.
Chamoun Z, Mann RK, Nellen D, von Kessler DP, Bellotto M, Beachy PA, Basler K
Science (New York, N.Y.) 2001 Sep 14;293(5537):2080-4
Science (New York, N.Y.) 2001 Sep 14;293(5537):2080-4
Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes.
Kawakami Y, Wang X, Shofuda T, Sumimoto H, Tupesis J, Fitzgerald E, Rosenberg S
Journal of immunology (Baltimore, Md. : 1950) 2001 Feb 15;166(4):2871-7
Journal of immunology (Baltimore, Md. : 1950) 2001 Feb 15;166(4):2871-7
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS